Randomized clinical trial to compare the effects of preoperative oral carbohydrate versus placebo on insulin resistance after colorectal surgery

British Journal of Surgery

Volumn 97, Issue 3, 2010, Pages 317-327

  Wang, Z G ^a   Wang, Q ^a   Wang, W J ^a   Qin, H L ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE TRANSPORTER 4; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SLC2A4 PROTEIN, HUMAN;

AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADMINISTRATION, ORAL; AGED; BLOOD GLUCOSE; BLOTTING, WESTERN; CARBOHYDRATES; COLORECTAL NEOPLASMS; FASTING; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 76649140106     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6963     Document Type: Article

References (59)

1. Ljungqvist O, Sereide E. Preoperative fasting. BrJ Surg 2003;90: 400-406.
2. Svanfeldt M, Thorell A, Hausel J, Soop M, Rooyackers O, Nygren J et al. Randomized clinical trial of the effect of preoperative oral carbohydrate treatment on postoperative whole-body protein and glucose kinetics. BrJ Surg 2007; 94: 1342-1350. (Pubitemid 350144381)
3. Rapp-Kesek D, Stridsberg M, Andersson LG, Berne C, Karlsson T. Insulin resistance after cardiopulmonary bypass in the elderly patient. Scand CardiovascJ 2007; 41: 102-108. (Pubitemid 46605385)
4. Ljungqvist O, Nygren J, Thorell A. Modulation of post-operative insulin resistance by pre-operative carbohydrate loading. ProcNutr Soc 2002; 61: 329-336. (Pubitemid 34982922)
5. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin NutrMetab Care 1999;2:69-78. (Pubitemid 129628628)
6. Ljungqvist O, Nygren J, Soop M, Thorell A. Metabolic perioperative management: novel concepts. Curr Opin Crit Care 2005; 11:295-299. (Pubitemid 41248299)
7. Yuill KA, Richardson RA, Davidson HI, Garden OJ, Parks RW. The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively - a randomised clinical trial. Clin Nutr 2005; 24:32-37.
8. Henriksen MG, Hessov I, Dela F, Hansen HV, Haraldsted V, Rodt SA Effects of preoperative oral carbohydrates and peptides on postoperative endocrine response, mobilization, nutrition and muscle function in abdominal surgery. Acta Anaesthesiol Scand 2003; 47: 191-199. (Pubitemid 36349780)
9. Crowe PJ, Dennison A, Royle G. The effect of pre-operative glucose loading on postoperative nitrogen metabolism. Br J Surg 1984; 71: 635-637. (Pubitemid 14098956)
10. Soop M, Nygren J, Thorell A, Weidenhielm L, Lundberg M, Hammarqvist F et al. Preoperative oral carbohydrate treatment attenuates endogenous glucose release 3 days after surgery. Clin Nutr 2004; 23: 733-741. (Pubitemid 39107054)
11. Brandi LS, Frediani M, Oleggini M, Mosca F, Cerri M, Boni C et al. Insulin resistance after surgery: normalization by insulin treatment. Clin Sci 1990; 79: 443-450.
12. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367. (Pubitemid 34940724)
13. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79: 992-1000.
14. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449-461. (Pubitemid 43200296)
15. Krinsley JS. Glycémie control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemie management: six and one-half years experience at a university-affiliated community hospital. Semin Thorac Cardiovasc Surg 2006; 18: 317-325.
16. Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery 2009; 146: 922-930.
17. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96. (Pubitemid 43278292)
18. Lund S, Pryor PR, Ostergaard S, Schmitz O, Pedersen O, Holman GD. Evidence against protein kinase B as a mediator of contraction-induced glucose transport and GLUT4 translocation in rat skeletal muscle. FEBS Lett 1998; 425: 472-474. (Pubitemid 28178853)
19. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M et al. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 1995; 136: 4315-4322.
20. Tanti JF, Grémeaux T, Grillo S, Calleja V, Klippel A, Williams LT et al. Overexpression of a constitutively active form of phosphatidylinositol 3 -kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem 1996; 271: 25 227-25232. (Pubitemid 26337887)
21. Kotani K, Carozzi AJ, Sakaue H, Hara K, Robinson LJ, Clark SF et al. Requirement for phosphoinositide 3 -kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1995; 209: 343-348.
22. Sakaue H, Ogawa W, Takata M, Kuroda S, Kotani K, Matsumoto M et al. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 1997; 11: 1552-1562. (Pubitemid 27366765)
23. Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 1998; 333: 471-490. (Pubitemid 28398511)
24. Svanfeldt M, Thorell A, Hausel J, Soop M, Nygren J, Ljungqvist O. Effect of 'preoperative' oral carbohydrate treatment on insulin action - a randomised cross-over unblinded study in healthy subjects. Clin Nutr 2005; 24: 815-821. (Pubitemid 41403638)
25. Guyatt GH, Townsend M, Berman LB, Keller JL. A comparison of Likert and visual analogue scales for measuring change in function. J Chronic Dis 1987; 40: 1129-1133. (Pubitemid 17158144)
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
27. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMAmodeling. Diabetes Care 2004; 27: 1487-1495.
28. Rijksen G, Van Oirschot BA, Staal GE. Nonradioactive assays of phospho-tyrosine kinase activity using anti-phosphotyrosine antibodies. Methods Enzymol 1991; 200: 98-107.
29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurements with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
30. van Erp HE, Rijksen G, van Veelen CW, van der Heijden JH, Maarschalkerweerd BN, Staal GE. Protein tyrosine kinases in human brain and gliomas. J Neurochem 1992; 58: 554-561.
31. Soop M, Nygren J, Myrenfors P, Thorell A, Ljungqvist O. Preoperative oral carbohydrate treatment attenuates immediate postoperative insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E576-E583. (Pubitemid 32466856)
32. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980; 65: 1272-1284. (Pubitemid 10122368)
33. Häring HU. The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 1991; 34: 848-861.
34. Sugita H, Kaneki M, Sugita M, Yasukawa T, Yasuhara S, Martyn JA. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle. Am J Physiol Endocrinol Metab 2005; 288: E585-E591. (Pubitemid 40250554)
35. Zhang Q, Carter EA, Ma BY, White M, Fischman AJ, Tompkins RG. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci 2005; 77: 3068-3077. (Pubitemid 41430280)
36. Krook A, Björnholm M, Galuska D, Jiang XJ, Fahlman R, Myers MG Jr et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 284-292. (Pubitemid 30071007)
37. Thompson LH, Kim HT, Ma Y, Kokorina NA, Messina JL. Acute, muscle-type specific insulin resistance following injury. Mol Med 2008; 14: 715-723.
38. Soeters MR, Sauerwein HP, Dubbelhuis PF, Groener JE, Ackermans MT, Fliers E et al. Muscle adaptation to short-term fasting in healthy lean humans. J Clin Endocrinol Metab 2008; 93: 2900-2903. (Pubitemid 352008568)
39. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianni F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63. (Pubitemid 30022895)
40. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-822. (Pubitemid 29220786)
41. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Arald-Sasaki R et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-365. (Pubitemid 32119139)
42. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999; 48: 1779-1786. (Pubitemid 29415197)
43. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301. (Pubitemid 30131733)
44. Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1991; 34: 488-499.
45. Donatelli F, Vavassori A, Bonfanti S, Parrella P, Lorini L, Fumagalli R et al. Epidural anesthesia and analgesia decrease the postoperative incidence of insulin resistance in preoperative insulin-resistant subjects only. Anesth Analg 2007; 104: 1587-1593. (Pubitemid 46791309)
46. Can MF, Yagci G, Dag B, Ozturk E, Gorgulu S, Simsek A et al. Preoperative administration of oral carbohydrate-rich solutions: comparison of glucometabolic responses and tolerability between patients with and without insulin resistance. Nutrition 2009; 25: 72-77.
47. Nygren J, Thorell A, Jacobsson H, Larsson S, Schnell PO, Hylén L et al. Preoperative gastric emptying. Effects of anxiety and oral carbohydrate administration. Ann Surg 1995; 222: 728-734. (Pubitemid 26001236)
48. Yagci G, Can MF, Ozturk E, Dag B, Ozgurtas T, Cosar A et al. Effects of preoperative carbohydrate loading on glucose metabolism and gastric contents in patients undergoing moderate surgery: a randomized, controlled trial. Nutrition 2008; 24: 212-216.
49. DeFronzo RA. Lilly Lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
50. Bogardus C, Lillioja S, Stone K, Mott D. Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 1984; 73: 1185-1190.
51. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990; 322: 223-228.
52. Thorell A, Nygren J, Hirshman MF, Hayashi T, Nair KS, Horton ES et al. Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization. Am J Physiol Endocrinol Metab 1999; 276: E754-E761. (Pubitemid 29211349)
53. Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P, Baron AD. Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998; 101: 2377-2386. (Pubitemid 28270432)
54. Zierath JR, He L, Gumà A, Odegoard Wahlström E, Klip A, Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 1996; 39: 1180-1189. (Pubitemid 126751334)
55. Ryder JW, Yang J, Galuska D, Rincón J, Björnholm M, Krook A et al. Use of a novel impermeable biotinylated photolabeling reagent to assess insulin- and hypoxia-stimulated cell surface GLUT4 content in skeletal muscle from type 2 diabetic patients. Diabetes 2000; 49: 647-654. (Pubitemid 30183755)
56. 31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 1998; 47: 381-386.
57. Tremblay F, Lavigne C, Jacques H, Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 2001; 50: 1901-1910. (Pubitemid 33641612)
58. Tremblay F, Lavigne C, Jacques H, Marette A. Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes 2003; 52: 29-37. (Pubitemid 36042104)
59. Han DH, Hansen PA, Host HH, Holloszy JO. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997; 46: 1761-1767. (Pubitemid 27456408)